Left a while ago but just curious how the Breast/Urology side if doing? Noticed seeing a lot of BC resumes lately at my position....dead end? How is the Urology side doing?
Sales are ok it's the company culture that is alarming very zombie and more like a scene from a reality show. information is excessive and we only use 30% of what we are required to know. Management will never take responsibility and consistently focus on someone else deflecting away from them. We recently took a survey about adding 2 new tests and time spent at each part of the Cancer network, we are late to market the liquid biopsy.
Prostate sales have approximately tripled every year. In 2014, sales were about 5 million. In 2015, 15 million and in 2016, 35 million. So far in 2017, we've done about $50 million. Test is rapidly becoming standard of care. The company will probably get aquired in the next year or 2. Stock has gone up 5 fold since I joined in mid 2013. I was one of the founding members on the urology side.
Not true, as a public company, revenue is reported. last quarter the prostate division brought just over 4 million. Will likely be a 15 million dollar year for prostate. Not standard of care and will likely die a slow death over the next 2-3 years.
Not true, as a public company, revenue is reported. last quarter the prostate division brought just over 4 million. Will likely be a 15 million dollar year for prostate. Not standard of care and will likely die a slow death over the next 2-3 years.
What stock are you talking about? I see about 27 five years ago and currently 30. Not hard to look up. Are you stupid or lying? .
